NovaBay Pharmaceuticals Inc (NBY) — Cash Flow Quality Index
NovaBay Pharmaceuticals Inc (NBY) has a Cash Flow Quality Index of -3.69x as of December 2017. Operating cash flow of $-2.93 Million is below net income of $793.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of NovaBay Pharmaceuticals Inc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
NovaBay Pharmaceuticals Inc Cash Flow Quality Index (2009–2009)
Historical Cash Flow Quality Index for NovaBay Pharmaceuticals Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check NBY total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for NovaBay Pharmaceuticals Inc (2009–2009)
Year-by-year earnings quality comparison for NovaBay Pharmaceuticals Inc. For live market cap and the full company financial profile, see NovaBay Pharmaceuticals Inc (NBY) total market value.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2009 | -0.61x | $-1.65 Million | $2.70 Million | — |